Germany
Japan
United Kingdom
China
Antibodies
View as table Download
Rabbit Polyclonal ZIPK Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | ZIP kinase antibody was raised against a peptide corresponding to amino acids near the center of human ZIP kinase. The immunogen is located within amino acids 270 - 320 of ZIPK. |
Rabbit Polyclonal antibody to CaMKII delta (calcium/calmodulin-dependent protein kinase II delta)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 249 and 445 of CaMK2D (Uniprot ID#Q13557) |
Rabbit polyclonal ETK / BMX(Ab-566) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human ETK around the phosphorylation site of tyrosine 566 (D-Q-YP-V-S). |
Rabbit polyclonal CSFR (Ab-809) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CSFR around the phosphorylation site of tyrosine 809 (S-N-YP-I-V). |
Rabbit polyclonal p38 MAPK (Ab-322) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human p38 MAPK around the phosphorylation site of tyreonine 322 (D-P-Y-D-Q). |
Rabbit Polyclonal antibody to FAST (Fas-activated serine/threonine kinase)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 346 and 549 of FAST (Uniprot ID#Q14296) |
Rabbit polyclonal COT (Ab-290) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human COT around the phosphorylation site of threonine 290 (R-G-TP-E-I). |
Rabbit polyclonal Ret (Ab-905) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Ret around the phosphorylation site of tyrosine 905 (D-S-YP-V-K). |
Rabbit polyclonal PDGFR beta (Ab-1021) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human PDGFR β around the phosphorylation site of tyrosine 1021 (N-D-YP-I-I). |
Rabbit polyclonal Raf1 (Ab-621) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human RAF1 around the phosphorylation site of serine 621 (S-A-S-E-P). |
Rabbit polyclonal Akt (Ab-129) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of serine 129 (D-N-SP-G-A). |
Rabbit polyclonal Akt (Ab-326) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human Akt around the phosphorylation site of tyrosine 326 (N-D-YP-G-R). |
Rabbit polyclonal PKA alpha/beta CAT (Thr197) antibody(Phospho-specific)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKA a/β CAT around the phosphorylation site of threonine 197 (T-W-TP-L-C). |
| Modifications | Phospho-specific |
Rabbit polyclonal c-Met (Ab-1003) antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human c-Met around the phosphorylation site of tyrosine 1003 (V-D-YP-R-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-PKC d antibody
| Applications | IF |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from Internal of human PKC d. |
Rabbit polyclonal Chk2 (Thr383) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Chk2 around the phosphorylation site of threonine 383 (M-R-TP-L-C). |
| Modifications | Phospho-specific |
Rabbit polyclonal CDK1/CDC2 (Thr14) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CDK1/CDC2 around the phosphorylation site of threonine 14 (E-G-TP-Y-G). |
| Modifications | Phospho-specific |
Rabbit polyclonal EPHA2/3/4 (Ab-588/596) antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human EPHA2/3/4 around the phosphorylation site of tyrosine 588/596 (T-YP-V-D-P). |
Rabbit polyclonal EPHA2/3/4 (Tyr588/596) antibody(Phospho-specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human EPHA2/3/4 around the phosphorylation site of tyrosine 588/596 (T-YP-V-D-P). |
| Modifications | Phospho-specific |
Rabbit polyclonal JAK2 (Ab-570) antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human JAK2 around the phosphorylation site of tyrosine 570 (G-D-YP-G-Q). |
Active filters
Category
- Antibodies
Reactivities
- Mouse
Applications
- IF
Antibody Hosts
- Rabbit
Isotypes
- IgG
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Target Symbol
- AKT1 (3)
- BMX (2)
- CDK2 (2)
- EPHA2 (2)
- ACVR1C (1)
- ACVRL1 (1)
- BCKDK (1)
- CAMK2D (1)
- CAMKV (1)
- CDK1 (1)
- CHEK2 (1)
- CLK1 (1)
- COQ8B (1)
- CSF1R (1)
- CSK (1)
- CSNK1A1 (1)
- CSNK1A1L (1)
- DAPK3 (1)
- EPHB1 (1)
- EPHB6 (1)
- FASTK (1)
- FRK (1)
- GRK6 (1)
- ICK (1)
- JAK1 (1)
- JAK2 (1)
- LIMK2 (1)
- MAP3K1 (1)
- MAP3K20 (1)
- MAP3K5 (1)
- MAP3K8 (1)
- MAP4K4 (1)
- MAPK14 (1)
- MAPK4 (1)
- MAPK6 (1)
- MAST4 (1)
- MET (1)
- MTOR (1)
- NLK (1)
- PAK2 (1)
- PDGFRB (1)
- PRKACA (1)
- PRKCD (1)
- PRKDC (1)
- PTK7 (1)
- RAF1 (1)
- RET (1)
- SGK1 (1)
- SLK (1)
- SNRK (1)
- STK11 (1)
Clonalities
Conjugates
Modifications
Pathways
- MAPK signaling pathway (15)
- Pathways in cancer (14)
- Neurotrophin signaling pathway (10)
- Chemokine signaling pathway (9)
- Progesterone-mediated oocyte maturation (9)
- Prostate cancer (8)
- Axon guidance (7)
- Colorectal cancer (7)
- ErbB signaling pathway (7)
- Focal adhesion (7)
- Glioma (7)
- T cell receptor signaling pathway (7)
- Adipocytokine signaling pathway (6)
- Fc epsilon RI signaling pathway (6)
- Fc gamma R-mediated phagocytosis (6)
- GnRH signaling pathway (6)
- Insulin signaling pathway (6)
- Melanoma (6)
- Oocyte meiosis (6)
- Pancreatic cancer (6)
- Renal cell carcinoma (6)
- Acute myeloid leukemia (5)
- Cell cycle (5)
- Chronic myeloid leukemia (5)
- Endocytosis (5)
- Jak-STAT signaling pathway (5)
- Regulation of actin cytoskeleton (5)
- Small cell lung cancer (5)
- Tight junction (5)
- Toll-like receptor signaling pathway (5)
- VEGF signaling pathway (5)
- Wnt signaling pathway (5)
- mTOR signaling pathway (5)
- Apoptosis (4)
- B cell receptor signaling pathway (4)
- Cytokine-cytokine receptor interaction (4)
- Endometrial cancer (4)
- Gap junction (4)
- Non-small cell lung cancer (4)
- p53 signaling pathway (4)
- Adherens junction (3)
- Calcium signaling pathway (3)
- Epithelial cell signaling in Helicobacter pylori infection (3)
- Hedgehog signaling pathway (3)
- Long-term potentiation (3)
- Melanogenesis (3)
- Vascular smooth muscle contraction (3)
- Amyotrophic lateral sclerosis (ALS) (2)
- Bladder cancer (2)
- Olfactory transduction (2)
- RIG-I-like receptor signaling pathway (2)
- TGF-beta signaling pathway (2)
- Type II diabetes mellitus (2)
- Dilated cardiomyopathy (1)
- Hematopoietic cell lineage (1)
- Leukocyte transendothelial migration (1)
- Long-term depression (1)
- NOD-like receptor signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- Non-homologous end-joining (1)
- Prion diseases (1)
- Taste transduction (1)
- Thyroid cancer (1)
- Ubiquitin mediated proteolysis (1)
- Vibrio cholerae infection (1)